Table of Contents
Amylin Pharmaceuticals, Inc.
Agenda
Amylin Pharmaceuticals, Inc.
Safe Harbor Statement
Current Pipeline Status
Amylin Goals for 2001SYMLIN™ (pramlintide acetate)
Amylin Goals for 2001AC2993 and AC2993 LAR
Amylin Goals for 2001AC3056 and Research
SYMLIN™ (pramlintide acetate)Overview
SYMLIN Patient FocusPeople With Diabetes Who Use Insulin
SYMLIN Market OpportunityUnited States
SYMLIN Market Opportunity: US Insulin Prescriptions Highly Concentrated
SYMLIN Commercial OperationsSales Planning Model
SYMLIN Commercial OperationsExperienced Core Commercial Team
Amylin the Hormone Campaign
Amylin the Hormone Campaign
Upcoming Medical Meetings
AC2993 (synthetic exendin-4)Overview
AC2993 (synthetic exendin-4)Patient Focus
AC2993 (synthetic exendin-4)Potential Markets
AC2993 (synthetic exendin-4)
AC2993 (synthetic exendin-4)
AC2993 LAR
AC3056
Expanding the Pipeline
Financial Overview
2001 Corporate Presentations
Goals for 2001
|